GAMMA Investing LLC Invests $41,000 in Teladoc Health, Inc. (NYSE:TDOC)

GAMMA Investing LLC purchased a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,921 shares of the health services provider’s stock, valued at approximately $41,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Lecap Asset Management Ltd. bought a new position in shares of Teladoc Health during the 4th quarter worth approximately $1,530,000. Sowell Financial Services LLC boosted its position in Teladoc Health by 40.8% in the fourth quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock worth $407,000 after purchasing an additional 5,475 shares during the last quarter. Deutsche Bank AG grew its stake in Teladoc Health by 12.4% in the 3rd quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock valued at $5,598,000 after purchasing an additional 33,287 shares during the period. Sherbrooke Park Advisers LLC purchased a new stake in shares of Teladoc Health during the 3rd quarter valued at $680,000. Finally, QRG Capital Management Inc. bought a new stake in shares of Teladoc Health during the 3rd quarter worth $392,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Trading Down 1.6 %

Teladoc Health stock opened at $12.78 on Friday. The company has a quick ratio of 3.47, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. Teladoc Health, Inc. has a fifty-two week low of $12.53 and a fifty-two week high of $30.41. The firm’s fifty day moving average price is $14.44 and its 200-day moving average price is $17.57.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The business had revenue of $646.13 million during the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The business’s revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the business earned ($0.37) EPS. As a group, analysts forecast that Teladoc Health, Inc. will post -1.04 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Laizer Kornwasser sold 10,411 shares of Teladoc Health stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the sale, the insider now directly owns 86,070 shares of the company’s stock, valued at approximately $1,092,228.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of Teladoc Health stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the transaction, the insider now directly owns 38,470 shares of the company’s stock, valued at $579,358.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Laizer Kornwasser sold 10,411 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the completion of the sale, the insider now directly owns 86,070 shares of the company’s stock, valued at approximately $1,092,228.30. The disclosure for this sale can be found here. Insiders sold a total of 138,368 shares of company stock valued at $1,989,227 in the last quarter. Corporate insiders own 0.95% of the company’s stock.

Analyst Ratings Changes

TDOC has been the subject of a number of research analyst reports. Oppenheimer decreased their price objective on shares of Teladoc Health from $26.00 to $21.00 and set an “outperform” rating for the company in a report on Friday, April 26th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Teladoc Health in a report on Monday, February 26th. Truist Financial reduced their price objective on Teladoc Health from $23.00 to $17.00 and set a “hold” rating for the company in a report on Wednesday, March 6th. Cantor Fitzgerald initiated coverage on Teladoc Health in a research note on Thursday, February 29th. They issued an “overweight” rating and a $22.00 target price on the stock. Finally, Canaccord Genuity Group cut their price target on Teladoc Health from $28.00 to $25.00 and set a “buy” rating for the company in a research note on Friday, April 26th. Twelve equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $18.73.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.